Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT03017326
Title	Paediatric Hepatic International Tumour Trial (PHITT)
Recruitment	Recruiting
Gender	both
Phase	Phase III
Variant Requirements	No
Sponsors	University of Birmingham
Indications	hepatocellular carcinoma hepatoblastoma
Therapies	Cisplatin Carboplatin + Etoposide Gemcitabine + Oxaliplatin + Sorafenib Cisplatin + Doxorubicin + Sorafenib Cisplatin + Doxorubicin + Gemcitabine + Oxaliplatin + Sorafenib Carboplatin + Doxorubicin Irinotecan + Vincristine Sulfate Cisplatin + Doxorubicin + Fluorouracil + Vincristine Sulfate Cisplatin + Doxorubicin Carboplatin + Cisplatin + Doxorubicin
Age Groups:	adult \| child
Covered Countries	GBR \| FRA \| ESP \| DEU \| BEL \| AUT